Journal Article DZNE-2020-04403

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury.

 ;  ;  ;  ;  ;  ;

2015
Biomed Central London

Acta Neuropathologica Communications 3(1), 13 () [10.1186/s40478-015-0198-y]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Interneuronal propagation of α-synuclein has been demonstrated in a variety of experimental models and may be involved in disease progression during the course of human synucleinopathies. The aim of this study was to assess the role that neuronal injury or, vice versa, cell integrity could have in facilitating interneuronal α-synuclein transfer and consequent protein spreading in an in vivo animal model.Viral vectors carrying the DNA for human α-synuclein were injected into the rat vagus nerve to trigger protein overexpression in the medulla oblongata and consequent spreading of human α-synuclein toward pons, midbrain and forebrain. Two vector preparations sharing the same viral construct were manufactured using identical procedures with the exception of methods for their purification. They were also injected at concentrations that induced comparable levels of α-synuclein transduction/overexpression in the medulla oblongata. α-Synuclein load was associated with damage (at 6 weeks post injection) and death (at 12 weeks) of medullary neurons after treatment with only one of the two vector preparations. Of note, neuronal injury and degeneration was accompanied by a substantial reduction of caudo-rostral propagation of human α-synuclein.Interneuronal α-synuclein transfer, which underlies protein spreading from the medulla oblongata to more rostral brain regions in this rat model, is not a mere consequence of passive release from damaged or dead neurons. Neuronal injury and degeneration did not exacerbate α-synuclein propagation. In fact, data suggest that cell-to-cell passage of α-synuclein may be particularly efficient between intact, relatively healthy neurons.

Keyword(s): Animals (MeSH) ; Brain: metabolism (MeSH) ; Disease Models, Animal (MeSH) ; Female (MeSH) ; Gene Transfer Techniques (MeSH) ; Humans (MeSH) ; Medulla Oblongata: metabolism (MeSH) ; Nerve Degeneration: metabolism (MeSH) ; Nerve Degeneration: pathology (MeSH) ; Neural Pathways: metabolism (MeSH) ; Neural Pathways: pathology (MeSH) ; Neurons: metabolism (MeSH) ; Neurons: pathology (MeSH) ; Parkinson Disease: metabolism (MeSH) ; Rats (MeSH) ; Rats, Sprague-Dawley (MeSH) ; alpha-Synuclein: metabolism (MeSH) ; SNCA protein, human ; alpha-Synuclein

Classification:

Contributing Institute(s):
  1. Neurodegeneration and Neuroprotection in Parkinson´s Disease (AG Di Monte)
  2. Translational Dementia Research Göttingen (AG Schneider Göttingen)
Research Program(s):
  1. 342 - Disease Mechanisms and Model Systems (POF3-342) (POF3-342)
  2. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)

Appears in the scientific report 2015
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; OpenAccess ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > GÖ DZNE > GÖ DZNE-AG Schneider Göttingen
Document types > Articles > Journal Article
Institute Collections > BN DZNE > BN DZNE-AG Di Monte
Full Text Collection
Public records
Publications Database

 Record created 2020-02-18, last modified 2024-08-26


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)